Zeta Global ZETA 深 滬
已收盤 10-17 16:00:00 美东时间
17.82
-0.410
-2.25%
華盛通- 最 高18.48
- 今 開17.88
- 成交量 707.36万股
- 最 低 17.46
- 昨 收 18.23
- 總市值 42.41亿
- 52周最高 38.20
- 市盈率 靜 --
- 換手率 2.97%
- 52周最低 10.69
- 委 比 -40.43%
- 總股本 2.38亿
- 歷史最高 38.20
- 量 比 0.76
- 振 幅 5.60%
- 歷史最低 4.09
- 每 手 1
- 風險率 7.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
Needham Reiterates Buy on Zeta Global Holdings, Maintains $25 Price Target
Needham analyst Scott Berg reiterates Zeta Global Holdings (NYSE:ZETA) with a Buy and maintains $25 price target.
10-09 18:05
SEC probes accounting practices at MassMutual - report
The U.S. Securities and Exchange Commission is probing private insurance and asset management giant Massachusetts Mutual Life Insurance over accounting standards in its investment business, according ...
10-09 05:19
NYSE Content Advisory: Pre-Market Update + S&P 500 comes off 1.1% weekly gain
NEW YORK, Oct. 6, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for m...
10-06 20:55
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
Acuity, Lithium Americas, Rezolve AI, AES And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
10-01 21:57
Analysts’ Top Technology Picks: Zeta Global Holdings Corp (ZETA), Wisetech Global (WTCHF)
There’s a lot to be optimistic about in the Technology sector as 2 analysts jus...
10-01 09:50
Zeta Global to Acquire Marigold's Enterprise Business For Up To $325M
Acquisition of Marigold's enterprise software business aligns with all of Zeta's guiding M&A principlesExpected to be accretive to adjusted EBITDA and free cash flow in year oneIncreases penetration of Fortune 500
10-01 04:06
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
09-23 09:52
DA Davidson Maintains Buy on Zeta Global Holdings, Raises Price Target to $27
DA Davidson analyst Clark Wright maintains Zeta Global Holdings (NYSE:ZETA) with a Buy and raises the price target from $25 to $27.
09-22 20:16
